abstract |
The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar 1 , Ar 2 , Ar 3 , L 1 , L 2 and Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases. |